mobile version

Pleural Mesothelioma/Peritoneal
Mesothelioma Symptoms
  and Diagnosis
Mesothelioma Staging
Treatment Options
Alimta Medication
Mesothelioma Clinical Trials
Types of Lung Cancer
Lung Cancer Symptoms
Lung Cancer Staging
Lung Cancer Treatment Options
Locations By State
Questions and Information
 From Your Doctor
VA Hospitals, Clinics, & Centers
Veteran Service Officers
History, Ships, & Shipyards
Mesothelioma News
Patient Stories
Web Resources
Patient Handout
Glossary of Terms
Contact us

 Search for information:
any search words
all search words

Click Here for a Free
Information Packet

Please call

We will gladly answer your
questions and send a free
packet with additional
information on:

  • New treatment options
  • New clinical trials
  • Doctors
  • Hazardous jobs and products
  • Veteran's Resources
  • Financial Assistance




Lung Cancer and Mesothelioma Information



Mesothelioma and Lung Cancer News - Return to Menu

EPA Needs Questionnaires from Residents Living Near Dearborn W.R. Grace Asbestos Site

CHICAGO, April 11 /U.S. Newswire/ -- U.S. Environmental Protection Agency Region 5 said equipment and more personnel are on site today to begin cleanup of the former W.R. Grace vermiculite-processing plant at 14300 Henn St. in Dearborn, Mich. Safety precautions such as water spray and other engineering controls will be used to reduce dust during the work.

Since sampling of nearby residential areas will begin Monday, April 18, EPA is urging owners of residential properties who want EPA to visually inspect their yards to return their white sheet questionnaires no later than Friday, April 15, to the EPA trailers at the Henn Street plant.

The cleanup will address asbestos-containing waste material from W.R. Grace's production of vermiculite that has been used, among other things, as an ingredient of potting soil. EPA has identified contamination at the former Grace plant (now owned by another business) and is investigating the possibility that some of the material may be in nearby yards or was used as fill in driveways. Grace operated at the Henn Street location from the early 1950s until 1989.

Information about the cleanup is available for review at Henry Ford Community College's Eshleman Library reference section, 5101 Evergreen Road. Materials in both English and Arabic are also available at the ACCESS Medical Center, 6450 Maple St.

Vermiculite is a natural occurring mineral compound composed of shiny flakes. Most vermiculite in the United States came from a mine near Libby, Mont., that also had a natural deposit of asbestos. Asbestos can cause health problems when breathed into the lungs and over time may result in lung diseases such as asbestosis, lung cancer or mesothelioma.

Contact: William Omohundro, 312-353-8254, Mick Hans, 312-353-5050, Dave Novak, 312-886-7478, all of the Environmental Protection Agency Region 5

Proposed asbestos trust would quickly go broke

September 19, 2005 - WASHINGTON DC. - According to a study released Monday, a proposed national trust fund for asbestos victims will go broke within three years of its' start. The analysis, done by the economic consulting firm Bates White, concluded that the proposed fund would face claims between $301 and $561 billion dollars, while the proposed budget of the fund was only $140 billion.

The estimate was much larger than an estimate released by the Congressional Budget Office last month, which predicted payouts between $120 and $150 billion over the next 30 years. However, the CBO estimate did not account for the probable rise in claims filed, instead using the current rate. The Bates White analysis included this variable, as the fund would create a new entitlement for those affected by cancer, but not currently compensated in court.


American Thoracic Society Journal news tips for October 2005 (second issue)

Californians who live close to naturally occurring asbestos source rocks and who are exposed to low levels of the mineral are at increased risk for malignant mesothelioma, a serious cancer of the pleural membrane covering the lungs, according to a new study.

For the research, investigators looked at 2,908 malignant mesothelioma cases reported over a 10-year period. Over 50 percent of the men and 58 percent of the women listed in the California Cancer Registry either had no or low occupational exposure to asbestos.

(Asbestos fibers can cause tumors in the two layers of membrane covering the lung (the pleura) or, with greater exposure, the membranes of the abdomen. Considered a rare cancer, meosothelioma usually takes 30 to 40 years after exposure to develop.)

According to the authors, California has more naturally occurring asbestos source rocks than any other state in the U.S., but their distribution is patchy, with exposed areas separated from unexposed areas.

The authors noted that the odds of being a mesothelioma case were 6.3 percent lower than the odds of being a study control patient with pancreatic cancer for each 6 miles (10 kilometers) they lived from the nearest asbestos source rocks.

Yet people who lived closer to naturally occurring asbestos deposits had a greater chance of developing the disease.

The authors explained that a major strength of the study was the very large number of mesothelioma cases used to assess the potentially weak association between exposure to naturally occurring asbestos and mesothelioma incidence.

The research appears in the second issue for October 2005 of the American Thoracic Society's peer-reviewed American Journal of Respiratory and Critical Care Medicine.


Researchers have developed a new clinical prediction rule that accurately classifies patients who have pulmonary embolism into five disease stages that show increasing risk of death or other adverse outcome.

To develop and test the rule, the investigators studied data from 15,531 discharged patients who had been hospitalized for pulmonary embolism at 186 Pennsylvania hospitals. For the study, the authors divided these patients into two groups: one to develop the rule and the other to verify their conclusions.

Acute pulmonary embolism represents a serious medical problem. It usually involves a blood clot that travels through the blood stream and suddenly blocks an artery of the lung. The most common type involves a blood clot that begins in either a leg or pelvic vein. Blood clots tend to develop where blood is flowing slowly such as can occur when an individual stays in one position too long. Once a clot breaks loose, it tends to travel to the lung.

According to the study, data from the National Hospital Discharge Survey show that in 2002, 101,000 patients with a primary diagnosis of pulmonary embolism were hospitalized in acute care hospitals in the United States, resulting in 676,700 inpatient days.

The researchers looked at 11 patient factors independently associated with 30-day patient mortality from pulmonary embolism. These were: two demographic factors (age and male sex); three illnesses (cancer, heart failure, and chronic lung disease); and six clinical findings related to such measurements as pulse, systolic blood pressure, respiratory rate, temperature, altered mental state (disorientation, lethargy, or stupor), plus the arterial oxygen saturation level. These readily available clinical parameters each were assigned a numerical score to quantify them with the patient's potential for death.

According to the authors, the rule identifies patients who are at either low or high risk of fatal and nonfatal medical outcomes associated with pulmonary embolism. For example, the 30-day mortality rate for a class I score was 1.6 percent or less. For class II, it was 3.5 percent. At class V, it ranged from 10 to 24.5 percent.

The investigators point out that, either through outpatient management or early hospital discharge of patients identified as very low risk in class I or low risk in class II, the rule could provide the potential for large cost savings without added risk to the patient. However, before the rule can be implemented in clinical practice, its clinical usefulness should be tested in a prospective study.

The research appears in the second issue for October 2005 of the American Thoracic Society's peer-reviewed American Journal of Respiratory and Critical Care Medicine.

Contact: Brian Kell
American Thoracic Society
For the complete text of these articles, please see the American Thoracic Society Online Web Site at http// For either contact information or to request a complimentary journalist subscription to ATS journals online, or if you would like to add your name to the Society's twice monthly journal news e-mail list, contact Brian Kell at (212) 315-6442, or by e-mail at

To Obtain the Best Treatment Info & Financial Assistance contact us for a FREE INFORMATION PACKET which includes:

Doctors & Cancer Hospitals
Clinical Trials
Hazardous Jobs/ Products
New Treatment Options
Veteran's Resources
Financial Assistance

Fill out the form below or call 1-800-400-1805.

Use the "tab" key to move to the next field, not enter.

First Name
Last Name



Have you or a loved one been diagnosed or have:

Yes   No
Lung Cancer:

Yes   No
Had a biopsy?:

Yes   No
Did you or your loved one work around asbestos?:
Yes   No

Comment /
Info Request

Please just hit the order button once, then wait for the form to be sent


Site Map | Mesothelioma | Alimta | Lung Cancer | Non-small cell lung cancer | Small cell lung cancer | Asbestos Lung Cancer | Lung Cancer Symptoms | Mesothelioma News | Mesothelioma Symptoms | Pleural Mesothelioma | Symptoms | Breaking News | Patient Handout | Treatment | Mesothelioma Patients | Mesothelioma Causes | Mesothelioma Climical Trials | Mesothelioma treatment | Veteran's Resources | Mesothelioma Treatments